Predictors of post-transplant survival in patients with newly diagnosed acute myeloid leukemia receiving frontline venetoclax and hypomethylating agents.

Authors: Isla Johnson, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Michelle A. Elliott, Abhishek A. Mangaonkar, Aasiya Matin, Antoine N. Saliba, Mehrdad Hefazi, William J. Hogan, Mithun Vinod Shah, Mrinal Patnaik, Animesh Dev Pardanani, Mark Robert Litzow, Ayalew Tefferi, Naseema Gangat

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18523

Source: Full article

---

Abstract

e18523